- Home
- QNRX vs HODO Comparison
QNRX vs HODO Comparison
Compare QNRX & HODO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$4.44
N/A
Current Price
$1.71
Company Overview
Basic Information| Metric | QNRX | HODO |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 8.4M |
| IPO Year | 2023 | 2025 |
Fundamental Metrics
Financial Performance| Metric | QNRX | HODO |
|---|---|---|
| Price | $4.44 | $1.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 325.3K | 166.5K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.25 | $1.65 |
| 52 Week High | $41.80 | $2.52 |
Technical Indicators
Market Signals| Indicator | QNRX | HODO |
|---|---|---|
| Relative Strength Index (RSI) | 49.98 | N/A |
| Support Level | $4.25 | N/A |
| Resistance Level | $5.11 | N/A |
| Average True Range (ATR) | 0.54 | 0.00 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 78.58 | 0.00 |
Price Performance
Historical Comparison QNRX
HODO
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.